Cargando…

Interferon-Free Hepatitis C Treatment before and after Liver Transplantation: The Role of HCV Drug Resistance

Hepatitis C virus (HCV) infection is one of the leading causes of end-stage liver disease and the main indication for liver transplantation (LT) in most countries. All patients who undergo LT with detectable serum HCV RNA experience graft reinfection progressing to cirrhosis within five years in 20%...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roche, Bruno, Coilly, Audrey, Roque-Afonso, Anne-Marie, Samuel, Didier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584308/ https://www.ncbi.nlm.nih.gov/pubmed/26404355 http://dx.doi.org/10.3390/v7092864

Ejemplares similares

Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin
por: Roche, Bruno, et al.
Publicado: (2015)

Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation
por: Samuel, Didier, et al.
Publicado: (2018)

Paediatric acute liver failure: Confirm the outbreak, find the cause and explore the mechanisms
por: Coilly, Audrey, et al.
Publicado: (2022)

New perspectives for preventing hepatitis C virus liver graft infection
por: Felmlee, Daniel J., et al.
Publicado: (2016)

Investigation of Inherited Chromosomally Integrated Human Herpesvirus-6A+ and -6B+ in a Patient with Ulipristal Acetate-Induced Fulminant Hepatic Failure
por: Izquierdo, Laure, et al.
Publicado: (2021)

Predictive factors of antibody response after anti-SARS-CoV-2 vaccine in liver transplant recipients
por: Kounis, Ilias, et al.
Publicado: (2022)

Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test
por: Mokhtari, Camelia, et al.
Publicado: (2016)

Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?
por: Meunier, Lucy, et al.
Publicado: (2022)

Advanced epithelioid hemangioendothelioma of the liver: could lenvatinib offer a bridge treatment to liver transplantation?
por: Kounis, Ilias, et al.
Publicado: (2022)

An HCV‐positive recipient of an HCV‐positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin
por: Poordad, Fred, et al.
Publicado: (2017)

FABP4 and MMP9 levels identified as predictive factors for poor prognosis in patients with nonalcoholic fatty liver using data mining approaches and gene expression analysis
por: Coilly, Audrey, et al.
Publicado: (2019)

Effect of interferon-free therapy on cognition in HCV and HCV/HIV infection: A pilot study
por: Kleefeld, Felix, et al.
Publicado: (2017)

Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?
por: Coilly, Audrey, et al.
Publicado: (2015)

Lymphoma Remission by Interferon-Free HCV Eradication Without Chemotherapy
por: Lim, Lucy Y., et al.
Publicado: (2015)

Treatment of HCV Patients Before and After Renal Transplantation
por: Du, Ling-yao, et al.
Publicado: (2011)

Foodborne Transmission of Hepatitis E Virus from Raw Pork Liver Sausage, France
por: Renou, Christophe, et al.
Publicado: (2014)

HCV replication in gastrointestinal mucosa: Potential extra-hepatic viral reservoir and possible role in HCV infection recurrence after liver transplantation
por: Russelli, Giovanna, et al.
Publicado: (2017)

The impact of the recipient and donor interferon lambda-3 polymorphism on the course of HCV infection following liver transplantation
por: Wieczorek-Godlewska, Renata, et al.
Publicado: (2017)

Early evolution of hepatitis C virus (HCV) quasispecies after liver transplantation
por: Stoll-Keller, F., et al.
Publicado: (2006)

Early Results of Pilot Study Using Hepatitis C Virus (HCV) Positive Kidneys to Transplant HCV Infected Patients with End-Stage Renal Disease Allowing for Successful Interferon-Free Direct Acting Antiviral Therapy after Transplantation
por: Gallegos-Orozco, Juan F, et al.
Publicado: (2016)

Evidence for Alloimmune Sinusoidal Injury in De Novo Nodular Regenerative Hyperplasia After Liver Transplantation
por: Sebagh, Mylène, et al.
Publicado: (2023)

Management of HCV Infection and Liver Transplantation
por: Schiano, Thomas D., et al.
Publicado: (2006)

Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection
por: Sung, Pil Soo, et al.
Publicado: (2015)

HCV cure without interferon
por: Bourlière, Marc
Publicado: (2014)

Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens
por: Tronina, Olga, et al.
Publicado: (2023)

Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation
por: Cortesi, Paolo Angelo, et al.
Publicado: (2023)

Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators
por: Van, Nguyen Dinh, et al.
Publicado: (2016)

Interferon Alpha Therapy in Patients with Chronic Type C Hepatitis: Changes of Serum ALT, Anti-HCV & HCV-RNA
por: Cho, Ho Jun, et al.
Publicado: (1992)

Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation
por: Grottenthaler, Julia M., et al.
Publicado: (2018)

HCV-infected Renal Transplant Recipients: Our Experience before the Availability of New Antiviral Drugs
por: Fernandes, A. R., et al.
Publicado: (2017)

The use of HCV positive donors among non-HCV infected liver transplant recipients
por: Zaffar, Duha, et al.
Publicado: (2022)

Interferon: A Sharp Sword to Overcome HCV or HBV-Related Liver Diseases?
por: Jia, Wei-Dong, et al.
Publicado: (2010)

Interferon-λ in HCV Infection and Therapy
por: Pagliaccetti, Nicole E., et al.
Publicado: (2010)

Successful Eradication of Hepatitis C Virus by Interferon-Free Regimens in Two Patients with Advanced Liver Fibrosis following Kidney Transplantation
por: Sasaki, Reina, et al.
Publicado: (2016)

Interferon-free regimens in patients with hepatitis C infection and renal dysfunction or kidney transplantation
por: Cholongitas, Evangelos, et al.
Publicado: (2017)

Recent advances in liver transplantation with HCV seropositive donors
por: Murag, Soumya, et al.
Publicado: (2019)

Genetic Variability of Hepatitis C Virus (HCV) 5’ Untranslated Region in HIV/HCV Coinfected Patients Treated with Pegylated Interferon and Ribavirin
por: Bukowska-Ośko, Iwona, et al.
Publicado: (2015)

Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy
por: Kapila, Nikhil, et al.
Publicado: (2019)

Long-Term Effectiveness, Safety, and Patient-Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study
por: Roche, Bruno, et al.
Publicado: (2022)

Outcomes in the Era of Interferon-Free Direct-Acting Antiviral Therapy After Liver Transplantation in Patients with Hepatitis C Virus and Hepatocellular Carcinoma
por: Ismail, Mohamed Saleh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jd3av38i2h6k2hm1umpm7cjtj1